Acute and chronic effects of ketamine upon human memory: a review

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Psychopharmacology

• Publication date

  2006-09-28

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-006-0572-3PMID 17006715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users.

  2006cited by this paper
• Are semantic deficits in schizophrenia due to problems with access or storage?

  2006cited by this paper
• Greater vulnerability to the amnestic effects of ketamine in males

  2006cited by this paper
• Ketamine displaces the novel NMDA receptor SPET probe [(123)I]CNS-1261 in humans in vivo.

  2006cited by this paper
• The Effects of a Subpsychotic Dose of Ketamine on Recognition and Source Memory for Agency: Implications for Pharmacological Modelling of Core Symptoms of Schizophrenia

  2006influential reference
• Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits.

  2006influential reference
• Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study.

  2005influential reference
• The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers

  2005cited by this paper
• Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

  2005cited by this paper
• A comparison of the effects of scopolamine and diazepam on working memory

  2005cited by this paper
• Altered prefrontal dopaminergic function in chronic recreational ketamine users.

  2005influential reference
• Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

  2005cited by this paper
• Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.

  2005cited by this paper
• Selective Cognitive Impairments Associated with NMDA Receptor Blockade in Humans

  2005influential reference
• Are semantic processing deficits in schizophrenia an access or storage problem

  2005cited by this paper
• Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task

  2005influential reference
• Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users.

  2004influential reference
• The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

  2004cited by this paper
• Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug.

  2004influential reference
• Acute Ketamine Administration Alters the Brain Responses to Executive Demands in a Verbal Working Memory Task: an fMRI Study

  2004cited by this paper
• Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.

  2004influential reference
• Increased neurogenesis in a rat ketamine model of schizophrenia.

  2004influential reference
• Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

  2004influential reference
• Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study

  2003cited by this paper
• Subdissociative Dose Ketamine Produces a Deficit in Manipulation but not Maintenance of the Contents of Working Memory

  2003influential reference
• Chronic Administration of Haloperidol and Olanzapine Attenuates Ketamine-Induced Brain Metabolic Activation

  2003cited by this paper
• Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose–response study

  2003influential reference
• The Seven Sins of Memory

  2003cited by this paper
• A randomized double-blind trial

  2003cited by this paper
• Neural structures that support implicit sequence learning

  2003cited by this paper
• Low dose ketamine increases prepulse inhibition in healthy men.

  2003influential reference
• Brain region-specific changes in the expression of calcium sensor proteins after repeated applications of ketamine to rats.

  2003cited by this paper
• Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

  2002cited by this paper
• NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans

  2002cited by this paper
• Behavioral and Functional Neuroimaging Evidence for Prefrontal Dysfunction in Methamphetamine-Dependent Subjects

  2002cited by this paper
• Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats

  2002cited by this paper
• Brain activation during automatic and controlled processing of semantic relations: a priming experiment using lexical-decision.

  2001cited by this paper
• NMDA receptor regulation of memory and behavior in humans

  2001cited by this paper
• In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users.

  2001influential reference
• A neurobiological basis for substance abuse comorbidity in schizophrenia.

  2001cited by this paper
• Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later.

  2000influential reference
• Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions.

  2000influential reference
• Glutamate receptor expression in schizophrenic brain.

  2000cited by this paper
• Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers

  2000influential reference
• Is MDMA (‘Ecstasy’) Neurotoxic in Humans? An Overview of Evidence and of Methodological Problems in Research

  2000cited by this paper
• Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

  2000cited by this paper
• Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

  2000cited by this paper
• Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity.

  2000cited by this paper
• Neural bases of learning and memory: functional neuroimaging evidence

  2000cited by this paper
• The episodic buffer: a new component of working memory?

  2000cited by this paper
• The Effects of a Sub-Anaesthetic Dose of Ketamine on Human Selective Attention

  2000cited by this paper
• Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

  1999influential reference
• The seven sins of memory. Insights from psychology and cognitive neuroscience.

  1999cited by this paper
• Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

  1999influential reference
• Functional mechanisms underlying impaired recognition memory and conscious awareness in patients with schizophrenia.

  1999cited by this paper
• Neurotransmitter interactions in schizophrenia--therapeutic implications.

  1999cited by this paper
• Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.

  1999cited by this paper
• Triazolam and zolpidem: effects on human memory and attentional processes

  1999cited by this paper
• The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

  1999influential reference
• Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

  1998cited by this paper
• The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report.

  1998cited by this paper
• Nosology and Vital Statistics of Dementing Conditions of Elderly People

  1998cited by this paper
• Impaired recruitment of the hippocampus during conscious recollection in schizophrenia

  1998cited by this paper
• Recent developments in working memory.

  1998cited by this paper
• Triazolam-induced changes in alcoholic thought processes

  1998cited by this paper
• Episodic and declarative memory: Role of the hippocampus

  1998cited by this paper
• The Apolipoprotein E ε4 Allele Is Associated with Blunting of Ketamine-Induced Psychosis in Schizophrenia: A Preliminary Report

  1998cited by this paper
• Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects

  1998cited by this paper
• Corticolimbic Dopamine Neurotransmission Is Temporally Dissociated from the Cognitive and Locomotor Effects of Phencyclidine

  1998influential reference
• Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers.

  1998influential reference
• A role for NMDA-receptor channels in working memory

  1998cited by this paper
• Principles of Neuropsychopharmacology

  1997cited by this paper
• Subchronic Phencyclidine Administration Reduces Mesoprefrontal Dopamine Utilization and Impairs Prefrontal Cortical-Dependent Cognition in the Rat

  1997cited by this paper
• Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

  1997influential reference
• Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

  1997cited by this paper
• Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

  1997influential reference
• A two-process theory of schizophrenia: evidence from studies in post-mortem brain.

  1997cited by this paper
• The functional neuroanatomy of episodic memory.

  1997cited by this paper
• NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine

  1996cited by this paper
• The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers

  1996influential reference
• Phencyclidine‐induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia

  1996cited by this paper
• NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

  1996influential reference
• Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment.

  1995cited by this paper
• The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat.

  1994cited by this paper
• Intrahippocampal administration of a glycine site antagonist impairs working memory performance of rats.

  1994cited by this paper
• A case of ketamine dependence.

  1994cited by this paper
• A case of ketamine dependence.

  1994cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994influential reference
• Dissociation of human mid-dorsolateral from posterior dorsolateral frontal cortex in memory processing.

  1993cited by this paper
• Negative Features, Retrieval Processes and Verbal Fluency in Schizophrenia

  1993cited by this paper
• Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.

  1992cited by this paper
• Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character

  1992cited by this paper
• NMDA antagonist neurotoxicity: mechanism and prevention.

  1991cited by this paper
• Recovery of neuropsychological functions during reduction in use of phencyclidine.

  1991cited by this paper
• Neuropsychological function in schizophrenia. Selective impairment in memory and learning.

  1991cited by this paper
• Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia.

  1991cited by this paper
• Ketamine--can chronic use impair memory?

  1990cited by this paper
• Total intravenous anesthesia for military surgery. A technique using ketamine, midazolam, and vecuronium

  1989cited by this paper
• Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs.

  1989cited by this paper
• Total intravenous anaesthesia for military surgery. A technique using ketamine, midazolam and vecuronium

  1988cited by this paper

• Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi-modal neuroimaging.

  2026cites this paper
• Acute ketamine withdrawal disrupts memory and monoaminergic neurotransmission in adolescent female rats.

  2026cites this paper
• Something is not nothing: Hair-tested substance use and cognitive functions in a large community sample of young adults

  2026cites this paper
• Antidepressant Effects of Nitrous Oxide in Major Depressive Disorder: A Phase 2b Randomized Clinical Trial

  2025cites this paper
• Molecular Mechanisms Underlying Chronic High-Dose Ketamine-Induced Apoptosis in the Hippocampus: A Narrative Review

  2025cites this paper
• Synergistic effects of capsaicin and ketamine on the depression-like behaviors of animals subjected to the chronic unpredictable mild stress protocol.

  2025cites this paper
• Unmasking the relationship between CGRP and glutamate: from peripheral excitation to central sensitization in migraine

  2025cites this paper
• Assessing Cognitive Function over Time in Patients with Refractory Chronic Migraine Who Received Ketamine Infusions: A Prospective, Observational Study

  2025cites this paper
• Opposing Modulation of EEG Aperiodic Component by Ketamine and Thiopental: Implications for the Noninvasive Assessment of Cortical E/I Balance in Humans

  2025cites this paper
• Influence of antipsychotic drugs on microglia-mediated neuroinflammation in schizophrenia: perspectives in an astrocyte–microglia co-culture model

  2025cites this paper
• Ketamine for Depression, but at What Cost? A Review of Ketamine's Neurotoxic Effects From Preclinical and Human Studies.

  2025cites this paper
• Ketamine administration during adolescence impairs synaptic integration and inhibitory synaptic transmission in the adult dentate gyrus.

  2025cites this paper
• Opposing Modulation of EEG Aperiodic Component by Ketamine and Thiopental: Implications for the Noninvasive Assessment of Cortical E/I Balance in Humans

  2025cites this paper
• Urological symptoms following ketamine treatment for psychiatric disorders: A systematic review

  2025cites this paper
• Navigating complex social interactions along the schizophrenia continuum: Is there a role for social-spatial memory in the formation of long-term social bonds?

  2024cites this paper
• Research trends and hotspots of ketamine from 2014 to 2023: a bibliometric analysis

  2024cites this paper
• No negative effects of intra-abdominal bio-logger implantation under general anaesthesia on spatial cognition learning in a hibernator the edible dormouse

  2024cites this paper
• Ketamine differentially affects implicit and explicit memory processes in rats

  2024cites this paper
• Abnormal resting-state functional connectivity of the right anterior cingulate cortex in chronic ketamine users and its correlation with cognitive impairments.

  2024cites this paper
• Widespread reductions in cortical thickness following ketamine abuse

  2024cites this paper
• Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine

  2024cites this paper
• Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial.

  2024cites this paper
• Age, Dose, and Locomotion: Decoding Vulnerability to Ketamine in C57BL/6J and BALB/c Mice

  2023cites this paper
• Sex-Specific Alterations in Spatial Memory and Hippocampal AKT-mTOR Signaling in Adult Mice Pre-exposed to Ketamine and/or Psychological Stress During Adolescence.

  2023cites this paper
• Exploratory evidence for differences in GABAergic regulation of auditory processing in autism spectrum disorder

  2023influential citation
• Ketamine: Recent application in administration of anesthesia, torment and medicare

  2023cites this paper
• Application of Ketamine in Pain Management and the Underlying Mechanism

  2023cites this paper
• Ketamine evoked disruption of entorhinal and hippocampal spatial maps

  2023cites this paper
• Alterations of neural activity in the prefrontal cortex associated with deficits in working memory performance

  2023cites this paper
• Toxicity patterns associated with chronic ketamine exposure

  2023cites this paper
• Sex-Dependent Attentional Impairments in a Subchronic Ketamine Mouse Model for Schizophrenia

  2023cites this paper
• Ameliorating effects of low-dose ketamine administrations on opioid-induced memory impairments and neurodegeneration in mice

  2023cites this paper
• Ketamine evoked disruption of entorhinal and hippocampal spatial maps

  2023cites this paper
• The Acute Effects of Psychoactive Drugs on Emotional Episodic Memory Encoding, Consolidation, and Retrieval.

  2023cites this paper
• The impact of depressive symptoms on cognitive impairments in chronic ketamine users.

  2023cites this paper
• Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia.

  2023cites this paper
• The thalamus in psychosis spectrum disorder

  2023cites this paper
• GABAergic regulation of auditory repetition suppression in adults with and without Autism Spectrum Disorder

  2023cites this paper
• Schizophrenia-like endurable behavioral and neuroadaptive changes induced by ketamine administration involve Angiotensin II AT1receptor.

  2022cites this paper
• Clinical and behavior characteristics of individuals who used ketamine

  2022cites this paper
• Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia

  2022cites this paper
• Is Multimodal Anesthesia Effecting Postoperative Nausea and Vomiting in Laparoscopic Cholecystectomy?

  2022cites this paper
• Comparative Evaluation of Thiopental Sodium and Ketamine Hydrochloride ‎in the Maintenance of General Anaesthesia during Exploratory Laparotomy ‎in Nigerian Indigenous Dogs

  2022cites this paper
• Ketamine plus Alcohol: What We Know and What We Can Expect about This

  2022cites this paper
• Ketamine Inhalation Alters Behavior and Lower Urinary Tract Function in Mice

  2022cites this paper
• The Effects of Acute and Repeated Administration of Ketamine on Memory, Behavior, and Plasma Corticosterone Levels in Female Mice.

  2022cites this paper
• Neurobiological, behavioral, and cognitive effects of ketamine in adolescents: a review of human and pre-clinical research.

  2022cites this paper
• Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review

  2022cites this paper
• Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions.

  2022cites this paper
• Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment

  2022cites this paper
• Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis.

  2022cites this paper
• Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders

  2022cites this paper
• Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019

  2021cites this paper
• Sedation; Is it Sleep, Is it Amnesia, What’s the Difference?

  2021cites this paper
• Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

  2021cites this paper
• Neurochemistry of Visual Attention

  2021cites this paper
• Methoxphenidine (MXP) induced abnormalities: Addictive and schizophrenia‐related behaviours based on an imbalance of neurochemicals in the brain

  2021cites this paper
• Neuropsychiatric disorders: An immunological perspective.

  2021cites this paper
• Contributions of animal models of cognitive disorders to neuropsychopharmacology.

  2021cites this paper
• Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review

  2021cites this paper
• Widespread Cortical Thickness Reductions Following Non-medical Use of Ketamine: a Structural MRI Study of Individuals with Ketamine Dependence

  2021cites this paper
• Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.

  2021cites this paper
• Ketamine for depression

  2021cites this paper
• (R,S)-ketamine and (2R,6R)-hydroxynorketamine differentially affect memory as a function of dosing frequency

  2021cites this paper
• Hazy memories in the courtroom: a review of alcohol and other drug effects on false memory and suggestibility.

  2021cites this paper
• Challenges and Controversies in Complex Regional Pain Syndrome (CRPS) Treatment

  2021cites this paper
• Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects.

  2021cites this paper
• A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties

  2021influential citation
• Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review

  2021cites this paper
• An Update to Aircrew Grounding Periods After Ketamine Use.

  2021cites this paper
• Uncaria rhynchophylla (Gouteng) ameliorates neuronal damage induced in a ketamine mouse model

  2020cites this paper
• Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers

  2020cites this paper
• What Are Club Drugs and NPS and Why Are They Important?

  2020cites this paper
• Profiling of behavioral effects evoked by ketamine and the role of 5HT2 and D2 receptors in ketamine-induced locomotor sensitization in mice.

  2020cites this paper
• Stimulant Drugs: Cocaine

  2020cites this paper
• The neurophysiology of ketamine: an integrative review

  2020cites this paper
• d-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders

  2020cites this paper
• Cognitive impairment in chronic ketamine abusers.

  2020cites this paper
• Designer drugs: mechanism of action and adverse effects

  2020cites this paper
• Brain Imaging of Ketamine Abusers

  2020cites this paper
• Synthetic Cannabinoid Receptor Agonists (SCRAs)

  2020cites this paper
• Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia

  2020cites this paper
• Introduction

  2020cites this paper
• Index

  2020cites this paper
• Depressant Drugs: Ketamine and Its Analogues

  2020cites this paper
• Effects of Ketamine on Learning and Memory in the Hippocampus of Rats through ERK, CREB, and Arc

  2020cites this paper
• Virtual reality-based cognitive training for drug abusers: A randomised controlled trial

  2020influential citation
• Stimulant Drugs: Amphetamine-Type Stimulants

  2020cites this paper
• Patient preferences for ketamine-based antidepressant treatments in treatment-resistant depression: Results from a clinical trial and panel

  2020cites this paper
• Depressant Drugs: Introduction

  2020cites this paper
• First-time offenders for recreational ketamine use under a new penalty system in Taiwan: incidence, recidivism and mortality in national cohorts from 2009 to 2017.

  2020cites this paper
• Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

  2020cites this paper
• A Brief History of NPS Production and Distribution

  2020cites this paper
• Depressant Drugs: Fentanyl, Fentanyl Analogues and Other Opioid NPS

  2020cites this paper
• Depressant Drugs: Benzodiazepine NPS

  2020cites this paper
• Update on Ketamine.

  2020cites this paper
• Classification Framework for Club Drugs and NPS

  2020cites this paper
• Club Drugs and Novel Psychoactive Substances

  2020cites this paper
• The Clinical Challenge of Club Drugs and NPS

  2020cites this paper
• Stimulant Drugs: MDMA and Drugs with Similar Effects

  2020cites this paper